Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study-Reference-Cited by-同舟云学术

Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study

Published:2009-09 Issue:9 Volume:50 Page:1832-1841
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Zhang Bo,Matsunaga Akira,Rainwater David L.,Miura Shin-ichiro,Noda Keita,Nishikawa Hiroaki,Uehara Yoshinari,Shirai Kazuyuki,Ogawa Masahiro,Saku Keijiro

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference39 articles.

1. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Circulation.,2004

2. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis;Kinlay;J. Am. Coll. Cardiol.,2007

3. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)—can C-reactive protein be used to target statin therapy in primary prevention?;Mora;Am. J. Cardiol.,2006

4. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method;Hirano;Arterioscler. Thromb. Vasc. Biol.,2004

5. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease;Holvoet;Circulation.,1998

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Electronegative LDL Act as a Multienzymatic Complex?;International Journal of Molecular Sciences;2023-04-11

2. Electronegative LDL Is Associated with Plaque Vulnerability in Patients with Ischemic Stroke and Carotid Atherosclerosis;Antioxidants;2023-02-10

3. The Association between Electronegative Low-Density Lipoprotein Cholesterol L5 and Cognitive Functions in Patients with Mild Cognitive Impairment;Journal of Personalized Medicine;2023-01-21

4. Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL;Pharmaceutics;2022-04-09

5. Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies;Journal of Clinical Medicine;2021-05-06